* PTA-ADHOC: MEDIGENE AG: MEDIGENE SUBMITS CTA FOR ITS FIRST TCR CLINICAL TRIAL AND ANNOUNCES MILESTONE PAYMENT

* EXPECTS TO START THIS TRIAL BY YEAR END 2017

* SUBMISSION TRIGGERS FINAL MILESTONE PAYMENT OF EUR 2.0 MILLION FROM MEDIGENE TO FORMER CONTRIBUTING SHAREHOLDERS OF MEDIGENE IMMUNOTHERAPIES GMBH WITHIN NEXT FIVE MONTHS

* INTENDS TO SETTLE THIS PAYMENT THROUGH ISSUANCE OF NEW SHARES FROM AUTHORIZED CAPITAL Source text for Eikon: Further company coverage: (Gdynia Newsroom)